Navigation Links
Arthritis sufferers fund arthritis research
Date:2/19/2008

The Queensland and Northern New South Wales Lions Medical Research Foundation, long time supporters of the Brisbane research community, have confirmed funding of $1.2 million for scientists at UQ's Diamantina Institute.

Dr Gethin Thomas will be the inaugural recipient of the $300,000 three-year fellowship, which will fund his research investigating the causes of ankylosing spondylitis (AS).

This is a form of arthritis affecting the spine resulting in joint fusion and immobility, and osteoporosis, a disease characterised by bone loss and frequent fracture.

This funding will enable us to focus on our longer-term goals of identifying the underlying causes of these diseases and developing new drugs and therapies, Dr Thomas said.

There is an urgent need for new therapies in these diseases that will enable reversal of disease damage.

The current therapies can only prevent progression of AS and osteoporosis but cannot repair already damaged bones and joints.

Unfortunately sufferers are frequently not diagnosed until fracture or loss of mobility by which time degeneration of the bones or joints is already significant.

Irene Dunning, Lions Foundation Chairman, said she was pleased Dr Thomas had received the first installment of the new Fellowship.

I think it's good to be supporting something which will potentially help a lot of Lions members," she said.

Osteoporosis and arthritis are diseases that affect many Lions members and their families and friends.

Lions members will further contribute to the research by volunteering as participants in the studies providing a valuable resource for our research efforts and creating a mutually beneficial synergy.


'/>"/>

Contact: Penny Robinson
penny.robinson@uq.edu.au
61-733-659-723
Research Australia
Source:Eurekalert

Page: 1

Related medicine news :

1. Study Suggests Glucosamine Wont Ease Hip Arthritis
2. Gene Linked to Inflammatory Arthritis Also Raises Heart Risks
3. Rheumatoid arthritis sends many into early retirement
4. Depression not discussed during rheumatoid arthritis doctor visits
5. The HLA-DRB1 gene and premature death in rheumatoid arthritis
6. Newer Rheumatoid Arthritis Drugs Lower Production of B Cells
7. Popular arthritis drug may disrupt heart rhythm, UB research finds
8. Exercise Program Eases Arthritis
9. A new view of drugs used to treat rheumatoid arthritis
10. Genes Linked to Height Also Tied to Osteoarthritis Risk
11. Modified-Release Prednisone May Ease Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... , ... Connor Sports, through its Connor Cares initiative, will continue ... Catchings Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and ... forms and levels of the game, Connor Sports has committed to a significantly increased ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... global clinical supply services, today announced two key appointments and the opening of ... strategic growth plans in the Asia Pacific region. , Howard Kim has joined ...
(Date:5/26/2016)... , ... May 26, 2016 , ... In an effort to provide hair restoration information ... both Snapchat users and those who do not use the app. Dr. Mohebi, the founder ... page, Dr. Mohebi Live . , Dr. Mohebi says, “The positive response to ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... comprehensive treatment for eating disorders, is opening a brand new child and adolescent ... ages 8-17 and their families with even more specialized eating disorder treatment and ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... 27, 2016 According to the ... is driving ambulatory blood pressure monitoring system market growth. ... their ability to respond to different pressure rates, leading ... lead to various cardiovascular disorders such as heart failure, ... diseases are growing in prevalence each year. WHO estimates ...
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharma company focused on the highly lucrative ... a substantial pipeline of potential first-in-class or best-in-class ... are in development with strategic partners. HCM,s profitable ... fast-growing domestic market. We expect progress of the ...
(Date:5/27/2016)... 2016 Kitov Pharmaceuticals ... on late-stage drug development, today announced the completion ... pivotal batches required for registration of KIT-302 with ... follows Kitov,s announcement in December 2015, ... its primary efficacy endpoint. "We are ...
Breaking Medicine Technology: